WHAT’S NEW
Keep up with the latest from NanoHive Medical, the pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation.
NanoHive Medical Announces $7M Series C Financing and Managing Directors Change
BOSTON, MA, August 5, 2024 - NanoHive Medical, a leader in 3D-printed titanium spinal interbody fusion devices, announces a $7M Series C Financing to capitalize the company’s rapid growth and a priority on company-building to profitability. Outcome Capital served as Strategic and Financial Advisor to NanoHive. The primary use-of-proceeds include: (i) expanding the U.S. commercial organization; (ii) expanding the company’s innovative Hive™ portfolio of Soft Titanium® spinal interbody fusion devices by way of product line-extensions, product launches, and “smart” sensor implant delivery research and development; (iii) entering select international markets; and (iv) expanding strategic...
NanoHive Medical Expands into New Markets with Distribution Partner HC Trade USA
BOSTON, MA., April 2, 2024 – NanoHive Medical, LLC, an innovative 3D printing spinal implant technology company, has entered into a distribution agreement with HC Trade USA, a leading global medical...
NanoHive Medical Secures a Venture Debt Round to Continue to Propel Commercialization
NanoHive Medical, LLC, a highly innovative spinal orthopedics company, is pleased to announce the closing of a venture debt round to support continued adoption of its proprietary Soft Titanium®...
NanoHive Medical and DirectSync Surgical to Collaborate on Patient-Powered SmartSpinal Implants
Leaders in the medical technology industry, NanoHive Medical and DirectSync Surgical, are pleased to announce a pioneering partnership poised to redefine spinal fusion procedures. The strategic...
NanoHive Medical, LLC Expands Hive™ 3D Printed Titanium Device Portfolio and Indications
NanoHive Medical has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its 22mm length Hive™ PL Interbody System. The 22mm length implants are a line extension to the...
NanoHive Medical, LLC Gains Approval with the Federal Supply Schedule for Portfolio of Hive™ Spinal Fusion Interbody Devices
NanoHive Medical announced today the award of a Federal Supply Schedule Contract by the US Department of Veteran Affairs (VA). The contract grants access to the Veteran’s Health Administration (VHA)...
NanoHive Medical at Spine Summit 2023
March 16-19th | Miami, FL | Booth 504
NanoHive Medical will be at TANS Conference
February 23 – 26 | Dallas, Texas
Visit us at Selby Spine Conference
February 2-4 | Park City, Utah
NanoHive Receives FDA 510(k) Clearance for Hive™ Standalone Cervical
NanoHive Medical has received 510(k) Clearance from the U.S Food and Drug Administration (FDA) for its Hive™ Standalone Cervical System. The implant system features both a zero profile design,...
Visit Us at the North American Spine Society (NASS) Annual Meeting
Visit Booth #2725 | October 12-15 | Chicago, IL
NanoHive Announces Significant Expansion of Patent Portfolio
NanoHive Medical today announced the expansion of its patent portfolio with the issuance of patent number US11,253,368 B2, Methods of Designing High X-Ray Lucency Lattice Structures. The patent is...
NanoHive Medical Announces Distribution Agreement With ACCELUS
Further expands distribution of NanoHive Medical’s Hive™Soft Titanium®3D printed interbody fusion technology BOSTON, Mass., February 21, 2022 – NanoHive Medical, LLC (previously HD LifeSciences), a...
NanoHive Medical Presents at Canaccord Genuity Conference 3.22.22
NanoHive Medical is excited to announce that the company has been selected to present at the Canaccord Genuity Musculoskeletal Conference, March 22, 2022. Patrick O’Donnell, President & CEO for...
Nanohive Medical Announces Kaveh Khajavi, MD as its New Medical Officer
BOSTON, MassNanoHive Medical, LLC (previously HD LifeSciences), a leading innovator in 3D printed, biomimetic spinal interbody fusion solutions, is excited to announce Kaveh Khajavi, MD, FACS, FAANS...
Nanohive Medical Announces Full Launch Of Hive™ Standalone ALIF
BOSTON, Mass., September 27, 2021 – NanoHive Medical, LLC (previously HD LifeSciences), a leading innovator in 3D printed, biomimetic spinal interbody fusion solutions, announced today the full...
HD Lifesciences Announces Name Change To Nanohive Medical
BOSTON, Mass., September 15, 2021 - HD LifeSciences LLC, a leading innovator in 3D printed spinal interbody fusion implants, today announced that it is changing the company's name to NanoHive...
HD Lifesciences Announces The Hiring Of Chief Financial Officer
Boston, MA, June 17, 2021 – HD LifeSciences, LLC is excited to announce that medical device veteran Tim Jette has joined the company as Chief Financial Officer. Tim brings significant finance...
HD LifeSciences Announces Expansion of Patent Portfolio
Boston, MA, March 3, 2021 – HD LifeSciences today announced the expansion of its patent portfolio with the issuance of patent number US10,888,429 B2, Three-Dimensional Lattice Structures for...
HD Lifesciences Kicks Off 2021 With New CEO
BOSTON, MA, February 3, 2021 - HD LifeSciences, LLC announced that industry veteran Patrick O’Donnell has joined the company as the new President & Chief Executive Office. For over 25 years,...
HD Lifesciences Surpasses 2500 Implant Milestone For Hive™ Interbody Fusion Device
BOSTON, MA - HD Lifesciences, LLC, a medical device company, has announced it has surpassed the milestone of 2500 implanted HIVE interbody devices since the formation of the company in late 2017....